...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Chinese-German Journal of Clinical Oncology >The Effects of Combined Hepatectomy and Imnunochemotherapy on Postoperative Recurrence of Primary Liver Cancer
【24h】

The Effects of Combined Hepatectomy and Imnunochemotherapy on Postoperative Recurrence of Primary Liver Cancer

机译：肝切除联合免疫化学治疗对原发性肝癌术后复发的影响

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To Study the effects of combined hepatectomy and immunochemotherapy on postoperative recurrence of primary liver cancer. Methods 121 cases were divided into four groups:operation only (OP group); combined operation and chemotherapy (OC group);combined operation and immunotherapy (OI group); combined operation and immunochemotherapy (OIC group). Chemotherapy was performed through hepatic artery or port vein, and the immunotherapy was used with LAK cell IL-2 and IFN-γ. Results Three-year recurrence rate in the four groups was 76.7% , 55.6% , 45.2% and 36.4% , respectively. The recurrence rate of OI group and OIC group was significantly lower than that of OP group. Conclusion Combined operation and immunochemotherapy is useful in preventing postoperative recurrence of primary liver cancer.
机译：目的研究肝切除联合免疫化学疗法对原发性肝癌术后复发的影响。方法将121例患者分为四组：单纯手术组（OP组）；单纯手术组（OP组）。手术联合化疗（OC组）；手术联合免疫疗法（OI组）；联合手术和免疫化学疗法（OIC组）。通过肝动脉或端口静脉进行化学疗法，对LAK细胞IL-2和IFN-γ进行免疫疗法。结果四组的三年复发率分别为76.7％，55.6％，45.2％和36.4％。 OI组和OIC组的复发率明显低于OP组。结论手术联合免疫化学疗法可预防原发性肝癌术后复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号